Mistaken Anthrax Shipments

The Defense Department reports that live samples of the deadly bacterium may have been accidentally shipped to more than 50 labs in the U.S. and abroad.

Written byJef Akst
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Photomicrograph of Bacillus anthracis bacteria WIKIMEDIA, CDCLast week (May 28), the US Department of Defense announced that an Army lab in Utah had mistakenly sent live anthrax spores to laboratories in nine states and one foreign country. Now, those numbers have grown to 18 states plus the District of Columbia and three countries abroad (Korea, Australia, and Canada). At least 52 labs are suspected to have received such live samples, which should have been inactivated by radiation prior to shipping, Pentagon officials said this week. And these tallies are likely to continue to grow, Defense Department officials warned, according to The New York Times.

While the Defense Department maintains that the mistaken shipments pose no danger to the public, 31 laboratory technicians, including active duty and civilian employees and contractors, are taking preventive medicine and being closely monitored. Twenty-two of these technicians are stationed at Osan Air Base, 30 miles from Seoul, South Korea, Military Times reported.

The Pentagon is working with the US Centers for Disease Control and Prevention to retrieve the samples. “We are acting with urgency . . . on this matter,” Deputy Defense Secretary Bob Work said in a Department of Defense news article. “We are going after it as fast as we can.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies